Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 410

1.
2.

Adalimumab: a review of its use in rheumatoid arthritis.

Bang LM, Keating GM.

BioDrugs. 2004;18(2):121-39. Review.

PMID:
15046527
3.

Meta-analysis of the efficacy and safety of adalimumab, etanercept, and infliximab for the treatment of rheumatoid arthritis.

Wiens A, Venson R, Correr CJ, Otuki MF, Pontarolo R.

Pharmacotherapy. 2010 Apr;30(4):339-53. doi: 10.1592/phco.30.4.339. Review.

PMID:
20334454
4.

Infliximab and methotrexate in the treatment of rheumatoid arthritis: a systematic review and meta-analysis of dosage regimens.

Zintzaras E, Dahabreh IJ, Giannouli S, Voulgarelis M, Moutsopoulos HM.

Clin Ther. 2008 Nov;30(11):1939-55. doi: 10.1016/j.clinthera.2008.11.007. Review.

PMID:
19108784
5.

Adalimumab for treating rheumatoid arthritis.

Navarro-Sarabia F, Ariza-Ariza R, Hernandez-Cruz B, Villanueva I.

Cochrane Database Syst Rev. 2005 Jul 20;(3):CD005113. Review.

PMID:
16034967
6.

Adalimumab for treating rheumatoid arthritis.

Navarro-Sarabia F, Ariza-Ariza R, Hernández-Cruz B, Villanueva I.

J Rheumatol. 2006 Jun;33(6):1075-81. Epub 2006 May 1. Review.

PMID:
16652437
7.

Tumor necrosis factor alpha drugs in rheumatoid arthritis: systematic review and metaanalysis of efficacy and safety.

Alonso-Ruiz A, Pijoan JI, Ansuategui E, Urkaregi A, Calabozo M, Quintana A.

BMC Musculoskelet Disord. 2008 Apr 17;9:52. doi: 10.1186/1471-2474-9-52. Review.

8.

Infliximab: an updated review of its use in Crohn's disease and rheumatoid arthritis.

Keating GM, Perry CM.

BioDrugs. 2002;16(2):111-48. Review.

PMID:
11985485
9.

Etanercept and infliximab for the treatment of psoriatic arthritis: a systematic review and economic evaluation.

Woolacott N, Bravo Vergel Y, Hawkins N, Kainth A, Khadjesari Z, Misso K, Light K, Asseburg C, Palmer S, Claxton K, Bruce I, Sculpher M, Riemsma R.

Health Technol Assess. 2006 Sep;10(31):iii-iv, xiii-xvi, 1-239. Review.

10.

[New drugs and treatment strategies for rheumatoid arthritis].

Fantini F.

Recenti Prog Med. 2003 Sep;94(9):361-79. Review. Italian.

PMID:
12942798
11.

Adalimumab for rheumatoid arthritis.

Voulgari PV, Drosos AA.

Expert Opin Biol Ther. 2006 Dec;6(12):1349-60. Review.

PMID:
17223742
12.

A single tumour necrosis factor haplotype influences the response to adalimumab in rheumatoid arthritis.

Miceli-Richard C, Comets E, Verstuyft C, Tamouza R, Loiseau P, Ravaud P, Kupper H, Becquemont L, Charron D, Mariette X.

Ann Rheum Dis. 2008 Apr;67(4):478-84. Epub 2007 Aug 2. Review.

13.

The number needed to treat for adalimumab, etanercept, and infliximab based on ACR50 response in three randomized controlled trials on established rheumatoid arthritis: a systematic literature review.

Kristensen LE, Christensen R, Bliddal H, Geborek P, Danneskiold-Samsøe B, Saxne T.

Scand J Rheumatol. 2007 Nov-Dec;36(6):411-7. Review.

PMID:
18092260
14.

Adalimumab: a review of its use in adult patients with rheumatoid arthritis.

Cvetković RS, Scott LJ.

BioDrugs. 2006;20(5):293-311. Review.

PMID:
17025376
16.

Indirect comparison of tocilizumab and other biologic agents in patients with rheumatoid arthritis and inadequate response to disease-modifying antirheumatic drugs.

Bergman GJ, Hochberg MC, Boers M, Wintfeld N, Kielhorn A, Jansen JP.

Semin Arthritis Rheum. 2010 Jun;39(6):425-41. doi: 10.1016/j.semarthrit.2009.12.002. Epub 2010 Mar 11. Review.

PMID:
20223500
17.
18.
19.

Anakinra for rheumatoid arthritis.

Mertens M, Singh JA.

Cochrane Database Syst Rev. 2009 Jan 21;(1):CD005121. doi: 10.1002/14651858.CD005121.pub3. Review.

PMID:
19160248
20.

[Adalimumab].

Goto D, Sumida T.

Nihon Rinsho. 2002 Dec;60(12):2384-9. Review. Japanese.

PMID:
12510366

Supplemental Content

Support Center